Safety Study of 90Y-hMN14 to Treat Colorectal Cancer Patients With Limited Residual Disease After Surgery - Related Studies

Safety Study of 90Y-hMN14 to Treat Colorectal Cancer Patients With Limited Residual Disease After Surgery

This study has been terminated.

Study NCT00041691. Last updated on June 23, 2005. Information provided by Immunomedics, Inc.

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Colorectal Neoplasms

2	Additional conditions recognized in this trial
		Neoplasms

3	More general conditions related to this trial
		Colonic Diseases
		Digestive System Diseases
		Digestive System Neoplasms
		Gastrointestinal Diseases
		Gastrointestinal Neoplasms
		Intestinal Diseases
		Intestinal Neoplasms
		Neoplasms by Site
		Rectal Diseases

4	Interventions listed in this trial
		hMN14 (labetuzumab)

5	Sponsors listed in this trial
		Immunomedics, Inc.